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INTRODUCTION:  A  wide  variety  of drugs  have  been  reported  to  cause  pancreatitis.  Although  the  inci-
dence  of  drug  induced  acute  pancreatitis  is  low, the disease  is associated  with  substantial  morbidity  and
mortality,  which  makes  timely  identiﬁcation  of  the causative  agent  important.
PRESENTATION OF  CASE:  Herein,  we report  two patients  with  clinical,  biochemical,  and radiological  evi-
dence  of acute  pancreatitis.  There  were  no etiologic  factors  except  their  prescribed  drugs.
DISCUSSION: The  majority  of patients  with  acute  pancreatitis  recover  uneventfully,  but there  remains  anrug induced acute pancreatitis
olinic  acid
orticosteroid
nti-neoplastic agents
ransverse  myelitis
uncontrollable  risk  of mortality.  It is prudent  to withdraw  a medication  with  a known  association  with
acute  pancreatitis.  Necessity  of multi-drug  regimens  especially  in  oncological  patients  however,  presents
a  challenge.
CONCLUSION:  Corticosteroid  pulse  therapy  was  easily  detectable  as  the causative  agent  in  our ﬁrst  case,
but  combined  anti-neoplastic  drug  therapy  and  additional  multi-drug  regimen  presented  great  difﬁcul-
ausa
gical  ties  in identifying  single  c
© 2013 Sur
. Introduction
Acute pancreatitis (AP) results from premature activation of
roteolytic enzymes within the pancreas. The spectrum of the dis-
ase varies from mild, which is usually self-limiting, to severe,
hich correlates with the degree of pancreatic involvement
nd complications.1 Bile duct stones and alcohol abuse together
ccount for about 80% of AP; other causes of AP are various tox-
ns, drugs, obstructive lesions of the bile duct system (other than
tones), metabolic abnormalities, trauma, ischemia, infections, and
utoimmune diseases.2 Occult biliary microlithiasis may  be the
ause of two-thirds of the ‘idiopathic’ cases which account for 10%
f AP.2
The pancreas is capable of biotransforming drugs and other
hemicals and is subject to toxic injury by the resulting reactive
etabolites.3 The proportion of drug induced pancreatitis is esti-
ated at 1.4%4 to 2%5 in the general population, with much higher
roportions in speciﬁc subpopulations, such as children (approxi-
ately 13%)6 and patients who are HIV positive.5
. Case 1A 58-year-old woman was consulted to our Emergency Surgery
nit from the Neurology Department of our hospital. She had
∗ Corresponding author at: Istanbul University, Istanbul Medical Faculty, Depart-
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Open access under CC BYtive  agent  in  our  second  patient.
Associates Ltd. Published by Elsevier Ltd. 
complained of severe abdominal pain lasting for the last 24 h. Phys-
ical examination revealed a predominantly epigastric pain which
radiates to the back. There was  no guarding or rebound, but ten-
derness, and the bowel sounds were frequent. There was no history
of alcohol or tobacco use or abdominal trauma. She had essential
hypertension for 15 years, hypothyroidism for two years and was
receiving 100 mg  Lysinopril and 100 g l-thyroxine daily. Serum
and urine amylase levels were elevated at 298 U/L (three times
normal) and 768 U/L (seven times normal), respectively. Serum
lipase level was  elevated to 2800 U/L (14 times normal). Liver
function tests were normal: GGT: 70 U/L (5–85 U/L), AST: 17 U/L
(5–42 U/L), ALT: 38 U/L (5–45 U/L). LDH was  elevated at 547 U/L
(240–480 U/L). Other causes of AP such as hyperlipidemia and
hypercalcemia were excluded. The white blood cell (WBC) count
was signiﬁcantly elevated at 17,630/mm3 (4000–10,000/mm3).
C-reactive protein was  signiﬁcantly elevated at 38.2 mmol/L (nor-
mal: <0.5 mmol/L). Abdominal ultrasound (US) examination and
computerized tomography (CT) scan revealed a normal liver and
biliary tract. CT scan also revealed the expansion of the head
of the pancreas and hyperdense mesenterium surrounding, both
of which were evidence of pancreatitis. The follow-up diagnosis
was transverse myelitis on the second day of pulse corticoste-
roid therapy. After steroid therapy, elevated blood glucose levels
were taken under control by regular insulin injections. We  did
not perform endoscopic retrograde cholangiopancreaticography
Open access under CC BY-NC-ND license.(ERCP)  because of the normal liver function tests and biliary tract
imaging. Corticosteroid therapy was stopped after lowering the
doses gradually in three days. The patient quickly improved and
was painless after six days. Conservative treatment resulted with
-NC-ND license. 
 –  O
 of Sur
s
n
3
U
s
S
m
f
c
(
m
p
c
t
t
l
f
A
n
a
w
p
e
m
b
s
ﬁ
4
c
a
a
r
t
i
u
i
c
a
u
b
e
s
v
s
i
e
i
s
t
I
t
A
a
8CASE  REPORT
F. Yanar et al. / International Journal
uccess. Control CT scan which was performed after 1 month was
ormal.
. Case 2
A  50-year-old woman was admitted to our Emergency Surgery
nit with 4 days of severe abdominal pain, loss of appetite, nau-
ea, and vomiting. There was no history of alcohol or tobacco use.
he underwent right hemicolectomy and ileotransversostomy two
onths ago, because of a right sided colonic adenocarcinoma. The
ourth dose of combination chemotherapy was given six days ago
onsisting of Camptotesin (Irinotecan) (125 mg/m2), 5-Fluorourasil
500 mg/m2) and Folinic acid (20 mg/m2). She was  also given Dexa-
ethasone (16 mg/day, i.v.) and Ondansetron (8 mg/day, i.v.) for
revention of emesis, Codeine (60 mg/day, p.o.) and NSAID (Piroxi-
am 20 mg  tablets/day) for pain relief and Omeprasole (40 mg/day)
ablets for gastric ulcer prophylaxis.
Serum and urine amylase levels were elevated at 284 U/L (three
imes normal), and 1988 U/L (19 times normal), respectively. Serum
ipase level was elevated at 3600 U/L (18 times normal). Liver
unction tests were within normal limits: ALP 82 U/L, GGT 80 U/L,
ST 32 U/L, and ALT 45 U/L. There was neither hyperlipidemia
or hypercalcemia. C-reactive protein was signiﬁcantly elevated
t 15.9 mmol/L (normal: <0.5 mmol/L). Abdominal US and CT scan
as revealed a normal biliary tract but the CT scan revealed multi-
le milimetrical metastatic lesions in the left lobe of the liver and
vidence of edematous pancreatitis. ERCP was not performed. All
edications were withdrawn and conservative management was
egun. Symptoms relieved and oral nutrition was started 36 h later,
peciﬁcally with improvement in both clinical and biochemical
ndings.
. Discussion
Regarding their certainty of causing AP, medications can be
lassiﬁed as Deﬁnite/Probable/Possible association.1,7 A ‘deﬁnite’
ssociation implies a total relationship of drug administration with
bdominal pain and hyperamylasemia or a positive response to
echallenge with the causative agent.1,7
The pathogenesis of drug induced pancreatitis does not appear
o differ from other causes of AP as discussed in several stud-
es in the literature.8–10 Exactly how medications induce AP is
nknown, but postulated mechanisms include immune-mediated
nﬂammatory response, direct cellular toxicity, pancreatic ductal
onstriction, arteriolar thrombosis, and metabolic effects.1,7
Most of the ‘evidence’ supporting associations between drugs
nd AP are based on anecdotal case reports.11 Relatively large vol-
mes of case-based evidence exist about drug induced pancreatitis,
ut little is known about the epidemiology and mechanisms of this
ntity.
Yashizawa and co-workers reported a case and a prospective
tudy in 1999 and stated that corticosteroid pulse therapy, using
ery high doses, may  cause pancreatitis that is unexpected and may
ometimes be fatal.12 On the other hand, there are many exper-
mental studies reporting that steroids could have a protective
ffect in acute phase of pancreatitis when they are administered by
ntravenous or intraductal route.13,14 These studies conclude that
teroid pulse therapy inhibits the development of AP by inhibi-
ion of leukocyte activation and the release of cytokines such as
L-1 beta and IL-6. These are the cytokines highly responsible for
he inﬂammatory process during the pathophysiological course of
P.14
In our ﬁrst case, there was a close relationship between drug
dministration and the onset of clinical symptoms (approximately
 h) and other causes of AP were easily excluded. As a deﬁnitePEN  ACCESS
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proof,  it is needed to see the recurrence of pancreatitis upon read-
ministration of the drug, but for ethical reasons rechallenge with
the suspected drug can only be done if the drug is necessary to
treat a serious condition,15 but such a necessity did not exist in our
case.
Our second case had many confounding pharmacological fac-
tors, but still conﬁrmed a diagnosis of AP. To the best of our
knowledge, Folinic acid was not previously reported as a causative
agent in AP, but codein,16 NSAID’s,11 omeprasole3 have all been
reported to have such a relationship. Combination therapy with
several medications related with AP has also been reported,1 but
management algorithms for such a challenging situation are lack-
ing in the literature. This forced us to report on this patient to
clarify that there may  be such challenging situations where demon-
strating a causal relationship between a single drug and AP may
sometimes be impossible. In one of the recent reviews, Nische et al.
reported an algorithm for the diagnosis and management of acute
pancreatitis.10 However, trying to detect only one drug or impli-
cating all the medications as causative agents is a question to be
answered. Identiﬁcation of a single drug of the patient’s treatment
and additive effects of several drugs associated with AP is needed
for establishing treatment strategies in the near future. To hear
about experiences of authors who had such cases would honor and
help us with our further patients. We  also agree with the authors
who did not recall evidence because of ethical reasons, consistent
statistical data, or evidence from experimental studies on a possible
mechanism to treat and to prohibit drawing deﬁnitive conclusions
about the drugs.5
The majority of patients with AP recover uneventfully, but
there remains an uncontrollable risk of mortality. It is prudent to
withdraw a medication with a known association with acute pan-
creatitis. Necessity of multi-drug regimens especially in oncological
patients however, presents a challenge. More studies are needed to
establish the risk proﬁles and to form therapeutic algorithms in the
ﬁeld of drug induced acute pancreatitis.
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